Abstract Submission

Abstract submission for EAU26 is closed. The outcome of abstract selection will be announced on 23 December, 2025.

The late-breaking submission period opens on 23 December, 2025. The final, updated late-breaking data must be submitted by 25 January, 2026 (23:59 CET) — the late-breaking deadline. 

Late-breaking abstracts are intended for high-impact research that was not complete or available by the regular submission deadline, 1 November, 23:59 CET.  Submissions must present novel, time-sensitive data of major scientific importance — such as results from pivotal clinical trials or breakthrough studies — that could not have been submitted or presented earlier. Late-breaking abstracts are subject to stricter selection criteria and must include robust, final data at the time of submission. Preliminary or incomplete data will not be accepted.

Like other abstracts, the information and data must not be published elsewhere prior to the meeting. Only abstracts that meet these standards will be considered for late-breaking presentation.

Placeholder abstract
Authors were required to submit a placeholder abstract by the regular submission deadline. The placeholder needed to include a provisional title, author list, and a brief description of the study's objective and rationale. Full abstracts which include results and conclusions must be submitted by the late-breaking deadline. Placeholder abstracts that are not completed during the late-breaking period will not be considered. 

Please note the following important conditions:

• Submissions that do not meet the criteria for late-breaking abstracts will be automatically rejected.
• Placeholder submission is done at the author’s own risk. Acceptance is not guaranteed, regardless of placeholder submission.
• The Scientific Committee will not respond to claims or disputes related to the acceptance or rejection of placeholder submissions.

Authors who did not submit a placeholder abstract by the regular submission deadline may still submit late-breaking abstract, provided it fully meets the late-breaking criteria outlined above. 

For a selected number of high-impact late-breaking abstracts, the EAU and European Urology are pleased to offer the possibility of  simultaneous publication, which enables authors to present their research at the annual EAU meeting concomitant to the publication online of their full article. This embargoed publication in our flagship journal includes fast-track submission with expedite review completed in 72 hours  and coordinated release of the manuscript on the day of presentation at the EAU Annual Congress.

Authors who wish to be considered for this opportunity should indicate so by contacting the abstract selection committee via h.kiss@uroweb.org. In that case, your full manuscript should be close to final form by the late-breaking abstract submission deadline. Candidate abstracts will be reviewed by the European Urology editorial team, and authors of abstracts deemed eligible will be invited to submit a full manuscript by the journal editor. As such, by letting us know, you give permission to share your abstract with the European Urology editorial team.

Please note that all submissions will undergo the standard rigorous peer-review process, and acceptance cannot be guaranteed. An invitation to submit reflects the journal's interest in your work but does not imply automatic publication.